A detailed history of Meritage Portfolio Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Meritage Portfolio Management holds 66,274 shares of JAZZ stock, worth $8.09 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
66,274
Previous 80,607 17.78%
Holding current value
$8.09 Million
Previous $8.98 Million 9.12%
% of portfolio
0.52%
Previous 0.55%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$107.32 - $127.74 $1.54 Million - $1.83 Million
-14,333 Reduced 17.78%
66,274 $8.16 Million
Q3 2024

Nov 04, 2024

SELL
$100.57 - $116.37 $77,539 - $89,721
-771 Reduced 0.95%
80,607 $8.98 Million
Q2 2024

Aug 08, 2024

SELL
$103.94 - $118.98 $120,466 - $137,897
-1,159 Reduced 1.4%
81,378 $8.69 Million
Q1 2024

Apr 29, 2024

SELL
$115.19 - $132.77 $288,205 - $332,190
-2,502 Reduced 2.94%
82,537 $9.94 Million
Q4 2023

Feb 02, 2024

BUY
$114.26 - $136.0 $540,107 - $642,872
4,727 Added 5.89%
85,039 $10.5 Million
Q3 2023

Oct 30, 2023

BUY
$122.0 - $145.31 $284,382 - $338,717
2,331 Added 2.99%
80,312 $10.4 Million
Q2 2023

Jul 31, 2023

SELL
$122.5 - $147.16 $892,902 - $1.07 Million
-7,289 Reduced 8.55%
77,981 $9.67 Million
Q1 2023

Apr 25, 2023

BUY
$133.98 - $160.47 $4.69 Million - $5.61 Million
34,987 Added 69.58%
85,270 $12.5 Million
Q4 2022

Feb 01, 2023

BUY
$129.72 - $159.85 $6.52 Million - $8.04 Million
50,283 New
50,283 $8.01 Million
Q3 2018

Oct 30, 2018

SELL
$161.01 - $180.57 $5.4 Million - $6.06 Million
-33,564 Closed
0 $0
Q2 2018

Jul 25, 2018

SELL
$146.33 - $183.18 $36,289 - $45,428
-248 Reduced 0.73%
33,564 $5.78 Million
Q1 2018

Apr 26, 2018

BUY
$135.59 - $157.16 $4.58 Million - $5.31 Million
33,812 New
33,812 $5.11 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.65B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Meritage Portfolio Management Portfolio

Follow Meritage Portfolio Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.